ImmusanT Expands Platform to Type 1 Diabetes with Investment from JDRF T1D Fund

Hansa Medical's board resolves on issue and repurchase of class C shares

Provention Bio Names Catlin to its Board of Directors

Stellar Biotechnologies to Supply KLH to US National Institutes of Health

Dr Susan Dillon joins Vedanta board of directors

Cablivi Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura

FDA Approves Merck's Delstrigo a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and Pifeltro, an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients

EU approval for Sanofi's Cablivi as a treatment for adults with aTTP

Celltrion Finalises Clinical Trials for Remsima SC, Planning to File a Marketing Authorization Application to the EMA in H2

European Commission Designates OMS721 as an Orphan Medicinal Product for Treatment in Hematopoietic Stem Cell Transplantation

FDA Grants Fast Track Designation for Phase 3 Trial of Inhaled Xenon Gas Therapy

China National Drug Administration Accepts Biologics License Application for Proposed Biosimilar to Humira 

Synthorx names new chief medical officer

Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis

Inova Diagnostics passes the US FDA clearance for the QUANTA Flash HMGCR for testing idiopathic inflammatory myopathy